Tattoos as a risk factor for malignant lymphoma: a population-based case-control study.

IF 9.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL EClinicalMedicine Pub Date : 2024-05-21 eCollection Date: 2024-06-01 DOI:10.1016/j.eclinm.2024.102649
Christel Nielsen, Mats Jerkeman, Anna Saxne Jöud
{"title":"Tattoos as a risk factor for malignant lymphoma: a population-based case-control study.","authors":"Christel Nielsen, Mats Jerkeman, Anna Saxne Jöud","doi":"10.1016/j.eclinm.2024.102649","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The popularity of tattoos has increased dramatically over the last few decades. Tattoo ink often contains carcinogenic chemicals, e.g., primary aromatic amines, polycyclic aromatic hydrocarbons, and metals. The tattooing process invokes an immunologic response that causes translocation of tattoo ink from the injection site. Deposition of tattoo pigment in lymph nodes has been confirmed but the long-term health effects remain unexplored. We used Swedish National Authority Registers with full population coverage to investigate the association between tattoo exposure and overall malignant lymphoma as well as lymphoma subtypes.</p><p><strong>Methods: </strong>We performed a case-control study where we identified all incident cases of malignant lymphoma diagnosed between 2007 and 2017 in individuals aged 20-60 years in the Swedish National Cancer Register. Three random age- and sex-matched controls per case were sampled from the Total Population Register using incidence density sampling. We assessed exposure through a questionnaire in 2021, and data on potential confounders were retrieved from registers. We used multivariable logistic regression to estimate the incidence rate ratio (IRR) of malignant lymphoma in tattooed individuals.</p><p><strong>Findings: </strong>The study population consisted of 11,905 individuals, and the response rate was 54% among cases (<i>n</i> = 1398) and 47% among controls (<i>n</i> = 4193). The tattoo prevalence was 21% among cases and 18% among controls. Tattooed individuals had a higher adjusted risk of overall lymphoma (IRR = 1.21; 95% CI 0.99-1.48). The risk of lymphoma was highest in individuals with less than two years between their first tattoo and the index year (IRR = 1.81; 95% CI 1.03-3.20). The risk decreased with intermediate exposure duration (three to ten years) but increased again in individuals who received their first tattoo ≥11 years before the index year (IRR = 1.19; 95% CI 0.94-1.50). We found no evidence of increasing risk with a larger area of total tattooed body surface. The risk associated with tattoo exposure seemed to be highest for diffuse large B-cell lymphoma (IRR 1.30; 95% CI 0.99-1.71) and follicular lymphoma (IRR 1.29; 95% CI 0.92-1.82).</p><p><strong>Interpretation: </strong>Our findings suggested that tattoo exposure was associated with an increased risk of malignant lymphoma. More epidemiologic research is urgently needed to establish causality.</p><p><strong>Funding: </strong>The Swedish Research Council for Health, Working Life and Welfare.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":null,"pages":null},"PeriodicalIF":9.6000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141277/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EClinicalMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eclinm.2024.102649","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The popularity of tattoos has increased dramatically over the last few decades. Tattoo ink often contains carcinogenic chemicals, e.g., primary aromatic amines, polycyclic aromatic hydrocarbons, and metals. The tattooing process invokes an immunologic response that causes translocation of tattoo ink from the injection site. Deposition of tattoo pigment in lymph nodes has been confirmed but the long-term health effects remain unexplored. We used Swedish National Authority Registers with full population coverage to investigate the association between tattoo exposure and overall malignant lymphoma as well as lymphoma subtypes.

Methods: We performed a case-control study where we identified all incident cases of malignant lymphoma diagnosed between 2007 and 2017 in individuals aged 20-60 years in the Swedish National Cancer Register. Three random age- and sex-matched controls per case were sampled from the Total Population Register using incidence density sampling. We assessed exposure through a questionnaire in 2021, and data on potential confounders were retrieved from registers. We used multivariable logistic regression to estimate the incidence rate ratio (IRR) of malignant lymphoma in tattooed individuals.

Findings: The study population consisted of 11,905 individuals, and the response rate was 54% among cases (n = 1398) and 47% among controls (n = 4193). The tattoo prevalence was 21% among cases and 18% among controls. Tattooed individuals had a higher adjusted risk of overall lymphoma (IRR = 1.21; 95% CI 0.99-1.48). The risk of lymphoma was highest in individuals with less than two years between their first tattoo and the index year (IRR = 1.81; 95% CI 1.03-3.20). The risk decreased with intermediate exposure duration (three to ten years) but increased again in individuals who received their first tattoo ≥11 years before the index year (IRR = 1.19; 95% CI 0.94-1.50). We found no evidence of increasing risk with a larger area of total tattooed body surface. The risk associated with tattoo exposure seemed to be highest for diffuse large B-cell lymphoma (IRR 1.30; 95% CI 0.99-1.71) and follicular lymphoma (IRR 1.29; 95% CI 0.92-1.82).

Interpretation: Our findings suggested that tattoo exposure was associated with an increased risk of malignant lymphoma. More epidemiologic research is urgently needed to establish causality.

Funding: The Swedish Research Council for Health, Working Life and Welfare.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
纹身是恶性淋巴瘤的风险因素:一项基于人群的病例对照研究。
背景:过去几十年来,纹身的流行程度急剧上升。纹身墨水通常含有致癌化学物质,如芳香族伯胺、多环芳香烃和金属。纹身过程会引起免疫反应,导致纹身墨水从注射部位转移。纹身颜料在淋巴结的沉积已得到证实,但其对健康的长期影响仍有待研究。我们利用覆盖全人口的瑞典国家权威机构登记册,调查了纹身暴露与恶性淋巴瘤总体以及淋巴瘤亚型之间的关系:我们进行了一项病例对照研究,在瑞典国家癌症登记册中确定了 2007 年至 2017 年期间诊断出的所有恶性淋巴瘤病例,这些病例的年龄在 20-60 岁之间。采用发病密度抽样法,从总人口登记册中为每个病例随机抽取了三个年龄和性别匹配的对照组。我们通过 2021 年的调查问卷评估了暴露情况,并从登记册中检索了潜在混杂因素的数据。我们使用多变量逻辑回归法估算了纹身者的恶性淋巴瘤发病率比(IRR):研究对象包括 11905 人,病例(n = 1398)的应答率为 54%,对照组(n = 4193)的应答率为 47%。病例的纹身率为 21%,对照组为 18%。纹身者患总体淋巴瘤的调整风险较高(IRR = 1.21;95% CI 0.99-1.48)。首次纹身时间与指数年相隔不到两年的人患淋巴瘤的风险最高(IRR = 1.81;95% CI 1.03-3.20)。随着接触时间的延长(三至十年),风险有所降低,但在指数年之前接受首次纹身≥11 年的人群中,风险再次升高(IRR = 1.19; 95% CI 0.94-1.50)。我们没有发现体表纹身面积越大,风险越高的证据。与纹身相关的风险似乎以弥漫大B细胞淋巴瘤(IRR 1.30;95% CI 0.99-1.71)和滤泡淋巴瘤(IRR 1.29;95% CI 0.92-1.82)最高:我们的研究结果表明,接触纹身与恶性淋巴瘤风险增加有关。迫切需要更多的流行病学研究来确定因果关系:瑞典健康、工作生活和福利研究委员会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
EClinicalMedicine
EClinicalMedicine Medicine-Medicine (all)
CiteScore
18.90
自引率
1.30%
发文量
506
审稿时长
22 days
期刊介绍: eClinicalMedicine is a gold open-access clinical journal designed to support frontline health professionals in addressing the complex and rapid health transitions affecting societies globally. The journal aims to assist practitioners in overcoming healthcare challenges across diverse communities, spanning diagnosis, treatment, prevention, and health promotion. Integrating disciplines from various specialties and life stages, it seeks to enhance health systems as fundamental institutions within societies. With a forward-thinking approach, eClinicalMedicine aims to redefine the future of healthcare.
期刊最新文献
A systematic review and network meta-analysis of psychological, psychosocial, pharmacological, physical and combined treatments for adults with a new episode of depression. Contribution of ethnicity, area level deprivation and air pollution to paediatric intensive care unit admissions in the United Kingdom 2008-2021. Tumor contour irregularity on preoperative CT predicts prognosis in renal cell carcinoma: a multi-institutional study. GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review. Incidence of new onset type 2 diabetes in adults living with obesity treated with tirzepatide or semaglutide: real world evidence from an international retrospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1